UHC – Delayed: Dex Z-Code Identifier Associated with Molecular Pathology Diagnostic Test Services Update

UnitedHealthcare Medicare Advantage previously communicated in the March Network Bulletin that effective June 1, 2021 in accordance with CMS guidelines providers would be required to submit claims with an appropriate DEX Z-Code identifier associated with Molecular Pathology Diagnostic Test Services provided.

• The policy will be applicable to both Facility and Professional Claims
  • Professional Lab Claims should fill out Loop 2400/SV101-7 for electronic or Box 19 for paper claims.
  • Facility Lab Services should fill out Line SV202-7 for electronic claims or Block 80 for paper claims.

The effective date of this policy has been delayed and will not be implemented June 1, 2021.

Source: https://www.uhcprovider.com/content/dam/provider/docs/public/policies/medadv-reimbursement/rpub/UHC-MEDADV-RPUB-JUN-2021.pdf